Skip Over Navigation Links

Feature Slides

  • Facebook icon
  • Twitter icon
  • YouTube icon
  • E-News Icon
  • Contact us Icon


Innovation in Rare Diseases

Grouping patients by shared disease characteristics enables more targeted treatment.

PharmExec on Sickle Cell
NCATS translational research partnership results in promising therapy.
Untreated cells from children with the genetic disease progeria (left) compared to similar cells treated with farnesyltransferase inhibitors.
Two African girls holding a sign that says